Your Vision. Our Mission.
We help technical founders turn their vision into the strategy, tactics, and tools that raise capital, drive adoption, and win customers. We bridge the gap between idea and execution.
Medical
Device
In Vitro
Diagnostics
Veterinary
Medicine
Cyber
Security
Disruptive
Technology
The Nissi Strategy + marketing Guarantee
"We get it done, no excuses."
Contracts are written as one-month renewals with a 30-day out clause.
If we don’t create value – fire us.
Our Name
Nissi
Hebrew Word
נִסִּי
Phonetic
nis-SEE
Meaning
rally flag, banner of victory
WHAT WE DO
From Capital Raise to Commercialization
Our team is uniquely positioned to help technical founders who have a real product but need the go-to-market muscle to turn it into a sustainable business. From the first investor to the first customer, we help them close the gap between vision and traction.
Raise Capital
We align your leadership team around a shared winning vision so you can pitch investors with clear data and real confidence.
Create Traction
We identify and target early adopters for your platform so you can build the credibility and excitement needed to scale fast.
From Zero to Revenue
We design the plan that wins your first customers and generates revenue, keeping investors confident and the next raise within reach.
How We Do It
The Proven Process
Our onboarding process is designed for speed and clarity. In four stages we diagnose what's missing, align as partners with your leadership team, and build your go-to-market plan. We deliver results.
01 Deep Discovery
We do a deep-dive on your platform technologies, messaging to investors, competitive and substitute landscape, and early commercial plan artifacts. We identify gaps, threats, and opportunities.
02 Align Strategy
We schedule an onsite alignment meeting with you and your team. Our report out from the Discovery phase informs a working day to fill gaps, mitigate threats, and exploit opportunities. The working output provides the clarity and focus needed to answer questions such as: What does winning look like? Who is your Ideal Customer? How do you identify the Early Adopter segment? In the end, we build out your strategic roadmap for winning Early Adopters — and then the Early Majority — with validated milestones.
03 Plan to Launch
Once alignment is achieved, the most tedious part of the process can begin — integration and strategy-building. We take your newly minted vision for success and design a path for you to get there. What results from this stage is everything you might need to move forward: brand strategy, marketing tactics, management tools, operational plans, product roadmaps, pitch decks, etc.
04 Execute to Win
We execute your plan, multiplying your effectiveness. No excuses. Our team of experts across investor relations, marketing, design, and sales enablement deploy to work hand-in-glove with your existing resources and team members. Your plans become deliverables: early adopter sites, secured capital, reduced friction, winning customers, generating revenue, at scale.
Who We Work With
Our Founding Clients
What founders, leaders, and their teams have to say about working with us.
"Have you ever met someone who is always willing to go the extra mile for you no matter how inconvenient? Levi embodies all of the characteristics I look for in a teammate and friend. He is loyal, possesses an unparalleled moral compass, and has an incredible skill for taking highly complex topics and boiling them down into digestible and manageable lessons. Levi is someone who can, and will, become an expert in anything he decides to work on. He will surpass any all expectations you place on him.
"You can count on him to do all of the right things. He possesses patients in abundance and has a never ending font of empathy. I would recommend him for whatever challenge you may be encountering."
Raymond Tarr, CEO, Sagacity Dx
"At Cytophenix, we’re building an innovative rapid antimicrobial susceptibility test platform technology from down in Western Australia. We first engaged Levi and his team to help us address one of the big challenges for any pre-market diagnostics company in our position: how do you build out a robust US market entry strategy while not immersed in the local ecosystem day-to-day?
"They have proven adept at helping us form the right questions to ask at every stage of the journey, advising and networking within the early-stage VC community, and helping us select and develop our pre-clinical early access program principal investigator (PI) candidates. Nissi have led our re-branding and re-launch — well-received amongst both investors and microbiologists — and helped us find our unique voice in the market. Though we are pre-revenue our management team believe our partnership with Nissi Strategy + Marketing to be worth the investment."
Dr. Kieran Mulroney, CEO, Cytophenix
Who We Are
Our Team
A team driven to leverage groundbreaking innovation into scaled enterprises that improve human flourishing and reduce human suffering.
Levi Kirwin
Founder + Principal
Levi Kirwin has spent his career at the intersection of science, strategy, and market execution — building go-to-market systems for founders and CEOs in industries where the complexity of the product demands more than a standard playbook. His firm, Nissi Strategy + Marketing, operates from Austin, Texas and serves clients in the US, EU, and APAC in healthcare, diagnostics, pharmaceuticals, cybersecurity, and emerging technologies.
Levi's background is broad and deep. He has worked as a bench microbiologist and analytical chemist, roles in medical device sales, global IVD marketing and sales team leader, Chief Commercial Officer, and CEO. He has built companion diagnostics strategy inside rare disease pharma, navigated FDA regulatory pathways for diagnostic devices, and developed full healthcare go-to-market strategies for companies entering the US market against established incumbents.
At Nissi Strategy + Marketing, our consulting team understands how to structure the investor narrative for VC and PE capital raise. With capital in hand we help founders build the physician KOL network and go-to-market architecture that makes a funding round defensible. We understand how hospital financial decision-makers think, how reimbursement pathways work, and how to build the outcomes and economic case that gets a new technology adopted at scale.
Areas of Expertise
• Pre-seed to Series A investor narrative
• Healthcare go-to-market strategy for regulated, science-forward industries
• FDA pathway navigation: BDD, NTAP, 510k, RUO/LDT
• Reimbursement architecture: DRG, NTAP, PLA, CPT, CMS and private payers
• Health outcomes and economic modeling (HOEM)
• Clinical trial structuring and early access program design
• Physician KOL development and KOL strategy
• Commercial team structuring for lean and high-impact revenue scaling
Sharmila Kirwin
Founder + Administrator
Sharmila Kirwin serves as Administrator for our team, bringing years of experience in relationship management, donor stewardship, and operations. Her career has included director roles in institutional advancement and patient advocacy at Texas Tech University and the Texas Tech University Health Sciences Center, where she worked to defend patient rights, resolve donor concerns, coordinate events, train employees, and develop systems for increasing satisfaction and elevating service standards. For the past twenty years she has poured her time into raising her family, applying the same discipline and attention to detail that now support Nissi Strategy + Marketing's campaign coordination and day-to-day organizational needs.
Matthew Reynolds
Custom Marketing Lead
Matthew Reynolds brings a unique blend of skills to the team at Nissi Strategy + Marketing, with his role sitting at the intersection of creative work and analytical thinking. Holding dual bachelor's degrees in Business Analytics and Environmental Science, he approaches marketing with a storyteller's eye, a problem-solver's mindset, and a scientist's precision. With experience ranging from SaaS startups to legacy OEMs, his background in graphic and web design, digital marketing, and copywriting has equipped him with a broad set of tools for helping teams translate complex ideas into clear, beautiful, and effective communication.
Chad Brueck
Strategy Consulting @ Brueck Advisory
Chad Brueck is the Founder & Principal of Brueck Advisory LLC, bringing nearly 20 years of in vitro diagnostics commercialization experience alongside the Nissi Strategy + Marketing team. He specializes in market assessment, commercial strategy, and launch planning — using structured, evidence-based frameworks to help companies translate their innovation into effective go-to-market execution.
Stu Amidon
Creative Partner @ Page50
Stu Amidon, founder of Page50 Marketing & Media, serves as a creative partner to Nissi Strategy + Marketing. He works closely with our team to deliver multimedia solutions — video production, professional photography, website design, messaging, and creative direction — to help our clients communicate about complex topics with investors, clinicians, and partners through clear, credible, and compelling storytelling that preserves scientific accuracy.
Work With Us
Ready to Cross the Chasm?
Let’s get your innovation to market.
Phone
Address
5900 Balcones Drive
Suite 100
Austin, TX 78731
United States
